Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer (Q46730211)
scientific article
Language:
Current Data About Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer
(P31) (Q13442814)
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P304) 188-196
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P407) (Q1860)

(P433) 3
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P478) 5
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P577) Thursday, September 1, 2005
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P921) (Q5452194)

(Q181600)

(Q188874)
(P887)

(Q422327)
(P887)

(P1433) (Q332277)
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P1476) "Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer" (language: en)
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P2093) Petra Kupsch
(P1545) 1
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Bernhard F Henning
(P1545) 2
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Katrin Passarge
(P1545) 3
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Heike Richly
(P1545) 4
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Katrin Wiesemann
(P1545) 5
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Ralf A Hilger
(P1545) 6
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Max E Scheulen
(P1545) 7
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Olaf Christensen
(P1545) 8
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Erich Brendel
(P1545) 9
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Brian Schwartz
(P1545) 10
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Elke Hofstra
(P1545) 11
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Rudolf Voigtmann
(P1545) 12
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Siegfried Seeber
(P1545) 13
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

Dirk Strumberg
(P1545) 14
(P248)
(P698) 16197622
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16197622

(P2860) (Q27860760)
(P248)
(P813) Tuesday, May 24, 2022
(P854) https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766

other details
description scientific article

External Links
(P356) 10.3816/CCC.2005.N.030
(P698) 16197622